Jennifer Chien Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

RYTM Quotes by TradingView

Jennifer Chien is EVP, Head of North America of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 5,858 shares of RYTM, which is worth approximately $337,889. The most recent transaction as insider was on Feb 19, 2025, when has been sold 2,035 shares (Common Stock) at a price of $57.22 per share, resulting in proceeds of $116,442. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.86K
502.67% 3M change
85.57% 12M change
Total Value Held $337,889

Jennifer Chien Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 19 2025
SELL
Open market or private sale
$116,442 $57.22 p/Share
2,035 Reduced 25.78%
5,858 Common Stock
Feb 16 2025
BUY
Exercise of conversion of derivative security
-
5,500 Added 41.07%
7,893 Common Stock
Feb 13 2025
SELL
Open market or private sale
$69,890 $58.0 p/Share
1,205 Reduced 33.49%
2,393 Common Stock
Feb 12 2025
SELL
Open market or private sale
$102,366 $56.4 p/Share
1,815 Reduced 33.53%
3,598 Common Stock
Feb 11 2025
SELL
Open market or private sale
$59,052 $57.5 p/Share
1,027 Reduced 15.95%
5,413 Common Stock
Feb 11 2025
BUY
Exercise of conversion of derivative security
-
2,031 Added 23.98%
6,440 Common Stock
Feb 10 2025
SELL
Open market or private sale
$246,606 $58.87 p/Share
4,189 Reduced 48.72%
4,409 Common Stock
Feb 09 2025
BUY
Exercise of conversion of derivative security
$51,856 $6.8 p/Share
7,626 Added 47.0%
8,598 Common Stock
Feb 05 2025
SELL
Open market or private sale
$187,056 $61.01 p/Share
3,066 Reduced 75.93%
972 Common Stock
Feb 04 2025
SELL
Open market or private sale
$85,995 $59.43 p/Share
1,447 Reduced 26.38%
4,038 Common Stock
Feb 01 2025
BUY
Exercise of conversion of derivative security
-
4,513 Added 45.14%
5,485 Common Stock
Nov 11 2024
SELL
Open market or private sale
$4,489,716 $67.15 p/Share
66,861 Reduced 98.57%
972 Common Stock
Nov 11 2024
BUY
Exercise of conversion of derivative security
$1,254,988 $20.58 p/Share
60,981 Added 47.34%
67,833 Common Stock
Mar 20 2024
SELL
Open market or private sale
$707,153 $38.78 p/Share
18,235 Reduced 72.69%
6,852 Common Stock
Mar 19 2024
SELL
Open market or private sale
$608,498 $39.22 p/Share
15,515 Reduced 38.21%
25,087 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
33,750 Added 45.39%
40,602 Common Stock
Feb 13 2024
SELL
Open market or private sale
$30,645 $49.83 p/Share
615 Reduced 8.24%
6,852 Common Stock
Feb 12 2024
SELL
Open market or private sale
$52,561 $51.38 p/Share
1,023 Reduced 12.05%
7,467 Common Stock
Feb 11 2024
BUY
Exercise of conversion of derivative security
-
2,031 Added 19.3%
8,490 Common Stock
Feb 09 2024
BUY
Exercise of conversion of derivative security
-
3,438 Added 34.74%
6,459 Common Stock
Feb 01 2024
SELL
Open market or private sale
$67,229 $45.06 p/Share
1,492 Reduced 33.06%
3,021 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
-
4,513 Added 50.0%
4,513 Common Stock
Nov 14 2023
SELL
Open market or private sale
$437,800 $32.01 p/Share
13,677 Reduced 100.0%
0 Common Stock
Nov 14 2023
BUY
Exercise of conversion of derivative security
$81,804 $6.8 p/Share
12,030 Added 46.8%
13,677 Common Stock
Nov 09 2023
SELL
Open market or private sale
$95,198 $27.69 p/Share
3,438 Reduced 67.61%
1,647 Common Stock
JC

Jennifer Chien

EVP, Head of North America
Boston, MA

Track Institutional and Insider Activities on RYTM

Follow RHYTHM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RYTM